Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms

Antitumour activity of docetaxel (Taxotere®) in hormone-dependent (HD) and hormone-independent (HID) prostate cancer PAC120 xenograft model was previously reported, and its level was associated with HER2 protein expression. In the present study, we evaluate the antitumour effects of docetaxel combin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Legrier, M-E, Oudard, S, Judde, J-G, Guyader, C, de Pinieux, G, Boyé, K, de Cremoux, P, Dutrillaux, B, Poupon, M-F
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2007
Assuntos:
Translational Therapeutics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2359985/
https://ncbi.nlm.nih.gov/pubmed/17211467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603553
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares